NASDAQ:EYES
Second Sight Medical Products, Inc.
- Stock
Last Close
4.36
31/08 04:00
Market Cap
210.05M
Beta: 2.56
Volume Today
35.77K
Avg: -
PE Ratio
−10.28
PFCF: −40.28
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 1.56M - | 3.40M 117.12% | 8.95M 163.40% | 3.98M 55.47% | 7.96M 99.85% | 6.90M 13.41% | 3.38M 51.00% | -500K 114.80% | -130K 74% | |
cost of revenue | 5.63M - | 3.56M 36.79% | 5.29M 48.76% | 10.08M 90.36% | 5.12M 49.22% | 4.89M 4.48% | 2.15M 55.97% | |||
gross profit | -4.06M - | -160.28K 96.06% | 3.66M 2,381.59% | -6.09M 266.56% | 2.85M 146.74% | 2.01M 29.47% | 1.23M 38.89% | -500K 140.75% | -130K 74% | |
selling and marketing expenses | 3.30M - | 6.84M 107.33% | 8.94M 30.54% | 8.99M 0.60% | 9.57M 6.45% | 11.34M 18.47% | 6.10M 46.18% | 701K 88.51% | ||
general and administrative expenses | 4.17M - | 6.57M 57.52% | 8.22M 25.25% | 10.08M 22.58% | 10.93M 8.45% | 10.69M 2.20% | 9.23M 13.71% | 5.94M 35.58% | 6.32M 6.26% | |
selling general and administrative expenses | 7.47M - | 13.41M 79.54% | 17.16M 27.95% | 19.07M 11.14% | 20.50M 7.51% | 22.03M 7.45% | 15.33M 30.42% | 6.64M 56.65% | 6.32M 4.95% | |
research and development expenses | 3.25M - | 5.04M 55.18% | 3.04M 39.77% | 5.35M 76.12% | 7.89M 47.62% | 10.01M 26.76% | 13.14M 31.36% | 4.84M 63.20% | 2.37M 50.99% | |
other expenses | 3.22M - | 2.62M 18.45% | 3.51M 33.87% | 2.70M 22.99% | 3.06M 13.28% | 4.60M 50.23% | 3.35M 27.09% | 1.69M 49.70% | 378K 77.59% | |
cost and expenses | 19.56M - | 24.63M 25.91% | 29.00M 17.72% | 37.20M 28.27% | 36.57M 1.67% | 41.52M 13.53% | 33.98M 18.17% | 12.67M 62.72% | 8.93M 29.48% | |
operating expenses | 13.93M - | 21.07M 51.24% | 23.70M 12.48% | 27.12M 14.41% | 31.46M 15.99% | 36.63M 16.46% | 31.82M 13.13% | 13.17M 58.63% | 9.06M 31.17% | |
interest expense | 5.01M - | 7.03M 40.30% | 29K 99.59% | 31K 6.90% | 93K 200% | 86K 7.53% | 362K 320.93% | 16K 95.58% | 12K 25% | |
ebitda | -17.64M - | -27.89M 58.10% | -19.65M 29.53% | -32.72M 66.46% | -27.97M 14.52% | -34.57M 23.63% | -32.83M 5.03% | -14.70M 55.23% | -8.84M 39.87% | |
operating income | -18.00M - | -21.23M 17.98% | -20.05M 5.59% | -33.21M 65.66% | -28.61M 13.85% | -35.18M 22.97% | -33.95M 3.48% | -14.90M 56.13% | -8.91M 40.19% | |
depreciation and amortization | 315.77K - | 279.18K 11.59% | 335K 19.99% | 432K 28.96% | 457K 5.79% | 435K 4.81% | 397K 8.74% | 164K 58.69% | 70K 57.32% | |
total other income expenses net | -4.97M - | -13.97M 180.96% | 29K 100.21% | 31K 6.90% | 93K 200% | 86K 7.53% | 362K 320.93% | 16K 95.58% | -12K 175% | |
income before tax | -22.97M - | -35.20M 53.26% | -20.02M 43.13% | -33.18M 65.75% | -28.52M 14.05% | -35.09M 23.07% | -33.59M 4.28% | -14.88M 55.70% | -8.92M 40.05% | |
income tax expense | 42.22K - | -6.93M 16,522.00% | 58K 100.84% | 62K 6.90% | 186K 200% | 172K 7.53% | 724K 320.93% | 32K 95.58% | 12K 62.50% | |
net income | -22.97M - | -35.20M 53.26% | -20.02M 43.13% | -33.18M 65.75% | -28.52M 14.05% | -35.09M 23.07% | -33.59M 4.28% | -14.88M 55.70% | -8.93M 39.97% | |
weighted average shs out | 1.57M - | 1.14M 27.65% | 1.62M 42.25% | 1.65M 1.84% | 2.26M 36.91% | 2.77M 22.58% | 612.83K 77.84% | 6.86M 1,019.12% | 10.94M 59.50% | |
weighted average shs out dil | 1.57M - | 1.14M 27.65% | 1.62M 42.25% | 1.65M 1.84% | 2.26M 36.91% | 2.77M 22.58% | 612.83K 77.84% | 6.86M 1,019.12% | 10.94M 59.50% | |
eps | -14.61 - | -30.94 111.77% | -12.37 60.02% | -20.13 62.73% | -12.64 37.21% | -12.69 0.40% | -54.81 331.91% | -2.17 96.04% | -0.82 62.21% | |
epsdiluted | -14.61 - | -30.94 111.77% | -12.37 60.02% | -20.13 62.73% | -12.64 37.21% | -12.69 0.40% | -54.81 331.91% | -2.17 96.04% | -0.82 62.21% |
All numbers in USD (except ratios and percentages)